BLEND LABS INC-A (BLND)
US09352U1088 - Common Stock
BLND gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 284 industry peers in the Software industry. BLND scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. While showing a medium growth rate, BLND is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
In the past year BLND has reported negative net income.
In the past year BLND has reported a negative cash flow from operations.
BLND had negative earnings in each of the past 5 years.
BLND had a negative operating cash flow in each of the past 5 years.
1.2 Ratios
BLND has a worse Return On Assets (-65.12%) than 87.32% of its industry peers.
The Return On Equity of BLND (-137.25%) is worse than 79.58% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -65.12% | ||
| ROE | -137.25% | ||
| ROIC | N/A |
ROA(3y)-94.31%
ROA(5y)-73.61%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
BLND has a Gross Margin of 53.64%. This is in the lower half of the industry: BLND underperforms 65.85% of its industry peers.
In the last couple of years the Gross Margin of BLND has declined.
The Profit Margin and Operating Margin are not available for BLND so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 53.64% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.98%
GM growth 5YN/A
2. Health
2.1 Basic Checks
BLND does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, BLND has more shares outstanding
The debt/assets ratio for BLND is higher compared to a year ago.
2.2 Solvency
Based on the Altman-Z score of -4.18, we must say that BLND is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of BLND (-4.18) is worse than 84.51% of its industry peers.
BLND has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -4.18 |
ROIC/WACCN/A
WACC10.76%
2.3 Liquidity
BLND has a Current Ratio of 3.43. This indicates that BLND is financially healthy and has no problem in meeting its short term obligations.
BLND has a better Current ratio (3.43) than 77.46% of its industry peers.
BLND has a Quick Ratio of 3.43. This indicates that BLND is financially healthy and has no problem in meeting its short term obligations.
BLND has a Quick ratio of 3.43. This is in the better half of the industry: BLND outperforms 77.82% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.43 | ||
| Quick Ratio | 3.43 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 59.37% over the past year.
The Revenue for BLND has decreased by -14.68% in the past year. This is quite bad
Measured over the past years, BLND shows a quite strong growth in Revenue. The Revenue has been growing by 17.78% on average per year.
EPS 1Y (TTM)59.37%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%77.78%
Revenue 1Y (TTM)-14.68%
Revenue growth 3Y17.78%
Revenue growth 5YN/A
Sales Q2Q%-5.45%
3.2 Future
Based on estimates for the next years, BLND will show a very strong growth in Earnings Per Share. The EPS will grow by 30.42% on average per year.
The Revenue is expected to grow by 17.66% on average over the next years. This is quite good.
EPS Next Y73.29%
EPS Next 2Y43.97%
EPS Next 3Y30.42%
EPS Next 5YN/A
Revenue Next Year2.66%
Revenue Next 2Y13.37%
Revenue Next 3Y17.66%
Revenue Next 5YN/A
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for BLND. In the last year negative earnings were reported.
Based on the Price/Forward Earnings ratio of 127.78, the valuation of BLND can be described as expensive.
Based on the Price/Forward Earnings ratio, BLND is valued a bit more expensive than the industry average as 61.62% of the companies are valued more cheaply.
BLND's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 21.99.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 127.78 |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
A more expensive valuation may be justified as BLND's earnings are expected to grow with 30.42% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y43.97%
EPS Next 3Y30.42%
5. Dividend
5.1 Amount
BLND does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
BLEND LABS INC-A
NYSE:BLND (9/18/2024, 6:40:01 PM)
After market: 3.95 +0.04 (+1.02%)3.91
-0.07 (-1.76%)
Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap994.08M
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 127.78 | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -65.12% | ||
| ROE | -137.25% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 53.64% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.82
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 3.43 | ||
| Quick Ratio | 3.43 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)59.37%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y73.29%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-14.68%
Revenue growth 3Y17.78%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y